Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Voyager Therapeutics Inc shares valued at $34,914 were sold by Fahey Sandell Jacquelyn on Oct 02 ’24. At $5.82 per share, Fahey Sandell Jacquelyn sold 5,999 shares. The insider’s holdings dropped to 86,001 shares worth approximately $0.69 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Fahey Sandell Jacquelyn purchased 5,999 shares, netting a total of over 34,920 in proceeds.
Before that, Swartz Robin had sold 1,357 shares from its account. In a trade valued at $13,407, the Chief Operating Officer traded Voyager Therapeutics Inc shares for $9.88 each. Upon closing the transaction, the insider’s holdings decreased to 1,357 shares, worth approximately $0.94 million.
As published in their initiating research note from Leerink Partners on October 16, 2024, Voyager Therapeutics Inc [VYGR] has been an Outperform and the price target has been revised to $15. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in late March. As of March 19, 2024, H.C. Wainwright has initiated its “Buy” rating for VYGR. Earlier on March 07, 2024, Citigroup initiated its rating. Their recommendation was “a Buy” for VYGR stock.
Analyzing VYGR Stock Performance
During the last five days, there has been a surge of approximately 16.59%. Over the course of the year, Voyager Therapeutics Inc shares have dropped approximately -5.09%. Shares of the company reached a 52-week high of $11.72 on 01/02/24 and a 52-week low of $5.71 on 10/01/24. A 50-day SMA is recorded $6.53, while a 200-day SMA reached $7.94. Nevertheless, trading volume fell to 0.57 million shares from 1.17 million shares the previous day.
Support And Resistance Levels for Voyager Therapeutics Inc (VYGR)
According to the 24-hour chart, there is a support level at 7.78, which, if violated, would cause prices to drop to 7.54. In the upper region, resistance lies at 8.17. The next price resistance is at 8.32. RSI (Relative Strength Index) is 68.06 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.78, which suggests the price will decrease in the coming days. Percent R is at 6.50%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
